BBIO vs CHD · rev $221.9M vs P/E 32, rev $6.11B
BridgeBio Pharma Inc (BBIO) versus Church & Dwight Company Inc (CHD) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
BBIO currently screens at market cap $13.24B. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Not investment advice. Open the BBIO and CHD stock pages for the full models.
Not investment advice.